Month: June 2013

Great news needs to be shared! It is so nice to see such dramatic and positive benefits from a treatment. The beauty of vaccines lies in their typical cost-effective and dramatic efficacy. In the June 19, 2013 Journal of Infectious …

HPV Vaccines Are Making a Difference! Read More »

Tagged with: , , , , ,

Biogen Idec’s Tecfidera (dimethyl fumarate) has been approved by the FDA for the treatment of people with relapsing forms of multiple sclerosis (MS).  The wholesale acquisition price for Tecfidera is reported to be $54,900,  about 9% less than the first MS …

Tecfidera for MS is $55,000 per year. Why? Read More »

Tagged with: , , , , , ,